Clinical and laboratory characteristics of ST-segment-elevation acute coronary syndrome depending on body mass index

Authors

DOI:

https://doi.org/10.14739/2310-1210.2026.1.339357

Keywords:

acute coronary syndrome with ST segment elevation, obesity, body mass index, atherosclerosis, inflammation

Abstract

Obesity is a critical risk factor for cardiovascular disease, specifically ST-segment elevation myocardial infarction (STEMI), and may influence clinical presentation, laboratory findings, and patient outcomes.

Aim. To identify clinical and laboratory features and evaluate the disease course in patients with acute coronary syndrome and ST segment elevation across different body mass index (BMI) categories.

Materials and methods. A non-randomized, open-label, prospective cohort study was conducted involving 120 patients with STEMI. Participants were categorized into three groups based on their BMI.

Results. In the obese group, a strong positive correlation was observed between troponin I levels and BMI (r = 0.632, t = 5.29, p < 0.001). A moderate correlation was found in the overweight group (r = 0.402, t = 2.86, p < 0.01). Furthermore, a statistically significant positive correlation between BMI and erythrocyte sedimentation rate (ESR) was identified in both the obese group (r = 0.663, t = 5.74, p < 0.001) and the overweight group (r = 0.312, t = 2.09, p = 0.042).

Conclusions. Obese patients demonstrated a more severe and clinically pronounced course of STEMI at the time of diagnosis and admission. Increased BMI was significantly associated with poorer STEMI outcomes, as evidenced by marked elevations in troponin I, ESR, respiratory rate, and heart rate in the obese cohort.

Author Biographies

V. A. Kovalenko, Zaporizhzhia State Medical and Pharmaceutical University

MD, Postgraduate student, Department of Internal Medicine 1

D. A. Lashkul, Zaporizhzhia State Medical and Pharmaceutical University

MD, PhD, DSc, Professor, Head of the Department of Internal Medicine 1

References

Cardiovascular diseases (CVDs) [Internet]. Who.int. [cited 2025 May 9]. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

Piché ME, Tchernof A, Després JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 2020;126(11):1477-500. doi: https://doi.org/10.1161/CIRCRESAHA.120.316101

Tramunt B, Smati S, Grandgeorge N, Lenfant F, Arnal JF, Montagner A, et al. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia. 2020;63(3):453-61. doi: https://doi.org/10.1007/s00125-019-05040-3

Feijóo-Bandín S, Aragón-Herrera A, Moraña-Fernández S, Anido-Varela L, Tarazón E, Roselló-Lletí E, et al. Adipokines and Inflammation: Focus on Cardiovascular Diseases. Int J Mol Sci. 2020;21(20):7711. doi: https://doi.org/10.3390/ijms21207711

Libby P. Inflammation during the life cycle of the atherosclerotic plaque. Cardiovasc Res. 2021;117(13):2525-36. doi: https://doi.org/10.1093/cvr/cvab303

Upur H, Li JL, Zou XG, Hu YY, Yang HY, Abudoureyimu A, et al. Short and long-term prognosis of admission hyperglycemia in patients with and without diabetes after acute myocardial infarction: a retrospective cohort study. Cardiovasc Diabetol. 2022;21(1):114. doi: https://doi.org/10.1186/s12933-022-01550-4

Bidzilya PP, Kadzharian VH. [Laboratory changes and prognostic indicators of the adverse course of chronic heart failure with preserved left ventricular ejection fraction, excess weight and concomitant atrial fibrillation]. Pathologia. 2023;19(3):201-6. Ukrainian. doi: https://doi.org/10.14739/2310-1237.2022.3.268186

Alpert MA, Karthikeyan K, Abdullah O, Ghadban R. Obesity and Cardiac Remodeling in Adults: Mechanisms and Clinical Implications. Prog Cardiovasc Dis. 2018;61(2):114-123. doi: https://doi.org/10.1016/j.pcad.2018.07.012

Henning RJ. Obesity and obesity-induced inflammatory disease contribute to atherosclerosis: a review of the pathophysiology and treatment of obesity. Am J Cardiovasc Dis. 2021;11(4):504-29. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8449192/

Clemente-Suárez VJ, Redondo-Flórez L, Beltrán-Velasco AI, Martín-Rodríguez A, Martínez-Guardado I, Navarro-Jiménez E, et al. The Role of Adipokines in Health and Disease. Biomedicines. 2023;11(5):1290. doi: https://doi.org/10.3390/biomedicines11051290

Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases Writing Group. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982-3021. doi: https://doi.org/10.1016/j.jacc.2020.11.010

Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289-367. doi: https://doi.org/10.1093/eurheartj/ehaa575

Halushko OA, Boliuk MV. [Features of the course of acute coronary syndrome in patients with diabetes]. DOMS. 2022;(5):23-8. Ukrainian. Available from: https://doms.org.ua/wp-content/uploads/2022/11/DOMS_5_2022-2-2Halushko-O.-A..pdf

Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, et al. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes Rev. 2020;21(11):e13128. doi: https://doi.org/10.1111/obr.13128. Erratum in: Obes Rev. 2021;22(10):e13305. doi: https://doi.org/10.1111/obr.13305

Konwerski M, Gąsecka A, Opolski G, Grabowski M, Mazurek T. Role of Epicardial Adipose Tissue in Cardiovascular Diseases: A Review. Biology (Basel). 2022;11(3):355. doi: https://doi.org/10.3390/biology11030355

Yao Y, Xue J, Li B. Obesity and sudden cardiac death: Prevalence, pathogenesis, prevention and intervention. Front Cell Dev Biol. 2022;10:1044923. doi: https://doi.org/10.3389/fcell.2022.1044923

Koureti G, Jain AK, Jain P, Jain A, Patidar M, Batham PR. Assessment of troponin I level in patients with acute myocardial infarction and its impact on clinical outcome: An observational study. International Journal of Health Sciences. 2022;6(S6):4241-8. doi: https://doi.org/10.53730/ijhs.v6nS6.10609

Huang J, Liu M, Su E, Yu P, Jiang H, Zhao J, et al. Elevated circulating high-sensitivity cardiac troponin t and cardiac remodeling in obesity. BMC Cardiovasc Disord. 2021;21(1):620. doi: https://doi.org/10.1186/s12872-021-02445-0

Yastremska IO. [Clinical features and treatment optimization in acute myocardial infarction with ST segment elevation in patients with comorbid metabolic syndrome] [dissertation on the Internet]. Ternopil: Ternopil National Medical University named after I. Gorbachevsky of the Ministry of Health of Ukraine; 2023. Ukrainian. Available from: https://nrat.ukrintei.ua/searchdoc/0823U100764/

Maslii BY. [Local anatomical and systemic determinants of predicting the severity of the course and choosing the volume of invasive intervention in patients with acute coronary syndrome] [dissertation on the Internet]. Ternopil : Ternopil National Medical University named after I. Gorbachevsky of the Ministry of Health of Ukraine; 2023. Ukrainian. Available from: https://nrat.ukrintei.ua/en/searchdoc/0823U100233/

Battineni G, Sagaro GG, Chintalapudi N, Amenta F, Tomassoni D, Tayebati SK. Impact of Obesity-Induced Inflammation on Cardiovascular Diseases (CVD). Int J Mol. Sci. 2021;22:4798. doi: https://doi.org/10.3390/ijms22094798

Nyshchuk-Oliinyk NB. [Features of myocardial remodelling in patients with stable coronary heart disease with concomitant type 2 diabetes mellitus: methods of medical correction] [dissertation on the Internet]. Ivano-Frankivsk: Ivano-Frankivsk national medical university; 2023. Ukrainian. Available from: https://nrat.ukrintei.ua/en/searchdoc/0824U001124/

Kuzmina IY, Kuzmina OO. Vplyv zhyrovoi tkanyny na rozvytok khronichnoho zapalennia na foni metabolichnoho syndromu [The influence of adipose tissue on the development of chronic inflammation in the context of metabolic syndrome]. In: Modern achievements of experimental, clinical, environmental biochemistry and molecular biology. Book of publications of I International scientific and practical online conference, dedicated to the 85th Anniversary of the Department of Biochemistry (Kharkiv, 2024 Mar 7). Kharkiv: NUPh; 2024. p. 378-85. Ukrainian.

Labinska OY. [Peculiarities of the course of myocardial infarction in patients with overweight and obesity] [dissertation on the Internet]. Lviv: Danylo Halytsky Lviv National Medical University; 2022. Ukrainian. Available from: https://nrat.ukrintei.ua/en/searchdoc/0823U100212/

Tashchuk VK, Bota RA. Effect of impaired myocardial contractility on coronary flow reserve and inflammatory processes in chronic coronary syndrome. Zaporozhye Medical Journal. 2024;26(4):269-74. Ukrainian. doi: https://doi.org/10.14739/2310-1210.2024.4.305572

Stepanov YM, Mosiychuk LM, Klenina IA, Tatarchuk ОМ, Petishko OP, Shevtsova OM. [Predictors of visceral obesity among patients with pathology of the gastrointestinal trac]. Gastroenterology. 2024;58(1):6-12. doi: https://doi.org/10.22141/2308-2097.58.1.2024.580

Additional Files

Published

2026-02-11

How to Cite

1.
Kovalenko VA, Lashkul DA. Clinical and laboratory characteristics of ST-segment-elevation acute coronary syndrome depending on body mass index. Zaporozhye Medical Journal [Internet]. 2026Feb.11 [cited 2026Feb.13];28(1):11-9. Available from: https://zmj.zsmu.edu.ua/article/view/339357